Human beings are big data. We aren’t just 175 pounds of meat and bone. We aren’t just piles of hydrogen and carbon and oxygen. What makes us all different is how it’s all organized and that is information. We can no longer treat people based on simple numbers like weight, pulse, blood pressure, and temperature. What makes us different is much more complicated than that. . . .
→ Read full post: Is Medicine a Big Data Problem?
This story about Claremont Creek Ventures’ portfolio Shotspotter covers how their new technology could improve how fast police respond to shootings inside schools and other buildings . . .
→ Read full post: Shotspotter’s New Technology Grabs Feature On CNN’s Erin Burnett Show
White House Champions of Change Award
This week Nat Kreamer, president and chief executive officer of CCV portfolio company Clean Power Finance, was honored at a White House ceremony with the “Champions of Change”/ “Veterans in Clean Energy and Climate Security” award. Atul Butte co-founder of Numedii, another CCV portfolio company, was also honored for the same “Champion of Change” award this . . .
→ Read full post: Claremont Creek Ventures Has Two Portfolio Companies Honored by White House for “Champions of Change” Award
We are stoked about our newest portfolio company Building Robotics who closed a seed round today at $1.14M.
click to see the latest news
Google Ventures plus many others invested with Claremont Creek Ventures, but we were the lead investor. The company had a ton of press for the . . .
→ Read full post: Our newest portfolio company Building Robotics closed a seed round today at $1.14M
Building Robotics’ initial product, Comfy, is the first to meaningfully reconnect people to the heating and cooling in their work environments, providing more comfortable spaces while saving energy. The software installs quickly and easily and is compatible with most existing building management systems, while providing occupants with a mobile and web application. It provides instant warm or cool air to people, while incorporating their usage patterns and feedback into a machine-learning algorithm that reduces energy. . . .
→ Read full post: Building Robotics, Maker of People-Centered Intelligent Software for Buildings, Announces $1.14M Seed Round
Our portfolio company NuMedii just announced a groundbreaking collaboration with Thomson Reuters, the world’s leading information provider for businesses. The Thomson Reuters Science division has quietly been aggregating an enormous database of biological, clinical, and pharmacological information over the past few years. As a biotech startup, NuMedii is focused on revolutionizing drug discovery by reducing the incredible inefficiencies and costs involved in small molecule drug development.
The drug development process is . . .
→ Read full post: Thomson Reuters and NuMedii Launch Initiative for Drug Discovery
Randy Hawks, Managing Director
It’s very cool that our portfolio company ShotSpotter was just profiled in the Washington Post (ShotSpotter detection system documents 39,000 shooting incidents in the District).
In Washington DC, ShotSpotter has 300 acoustic sensors across 20 square miles of the city, covering mainly the Southeast and Northeast of the District. ShotSpotter is a unique gunfire surveillance network that helps police respond quicker to gunfire incidents. These . . .
→ Read full post: Claremont Creek Ventures portfolio company Shotspotter was featured in the Washington Post
Our portfolio company Assurex Health, announced recently the publication of a groundbreaking analysis of pharmacogenomic data in the International Review of Psychiatry.
The publication strongly validates the premise that the clinical use of genomic testing to help predict patient response to psychiatric medications significantly improves treatment outcomes. This is a key milestone in the continuing discussions within the Psychiatric community about the value of laboratory testing in . . .
→ Read full post: Assurex Health Publishes Seminal Paper on Pharmacogenomics
Our portfolio company Genalyte just announced the award of a government grant from the National Cancer Institute for the development of a diagnostic system using Genalyte’s proprietary biomarker technology (see Genalyte Expands into Cancer Profiling with $1 Million NCI Grant to Develop Cancer Biomarker Panel). This project is a significant validation of the company’s capability to assay blood biomarkers using the multiplex Maverick detection platform, which provides rapid, accurate, . . .
→ Read full post: Genalyte Receives National Cancer Institute Grant
The Global Cleantech 100 Gala honored and celebrated the achievements of the 2013 Global Cleantech 100 companies, the 100 top innovators in cleantech today.
Two of Claremont Creek Ventures portfolio companies, Alphabet Energy and Clean Power Finance were named to the list to the top 100 Global Cleantech companies. . . .
→ Read full post: Alphabet Energy and Clean Power Finance honored at Global Cleantech 100 Gala